A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

摘要

HIT is characterized by thrombocytopenia, usually beginning 5 to 10?days after starting heparin therapy and poses a high risk of thromboembolic complications.